Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Tokyo - Delayed Quote JPY

Japan Tobacco Inc. (2914.T)

4,570.00
+68.00
+(1.51%)
As of 2:34:23 PM GMT+9. Market Open.
Loading Chart for 2914.T
  • Previous Close 4,502.00
  • Open 4,572.00
  • Bid 4,569.00 x --
  • Ask 4,569.00 x --
  • Day's Range 4,492.00 - 4,595.00
  • 52 Week Range 3,453.00 - 4,622.00
  • Volume 7,650,500
  • Avg. Volume 4,985,780
  • Market Cap (intraday) 8.114T
  • Beta (5Y Monthly) 0.20
  • PE Ratio (TTM) 45.32
  • EPS (TTM) 100.84
  • Earnings Date Jul 31, 2025
  • Forward Dividend & Yield 194.00 (4.32%)
  • Ex-Dividend Date Jun 27, 2025
  • 1y Target Est 4,590.00

Japan Tobacco Inc., a tobacco company, manufactures and sells tobacco products, pharmaceuticals, and processed foods in Japan and internationally. The company operates through three segments: Tobacco Business, Pharmaceutical Business, and Processed Food Business. It offers tobacco products, such as cigarettes, heat-not-burn tobacco products, E-vapor products, fine cut tobacco products, cigars, pipes, smokeless tobacco products, and hookah and kretek products. The company provides reduced-risk products, including infused tobacco capsules and heated tobacco sticks. In addition, it researches and develops, manufactures, and sells prescription drugs for the therapeutic areas, such as cardiovascular, kidney and metabolism, immunity/inflammation, and central nervous system. Further, the company provides frozen and room-temperature products, such as frozen udon noodles, packed rice, and frozen okonomiyaki; bakery products; and seasonings, including yeast extracts, assembled, kelp and bonito extracts, and oyster sauces. It offers its products under the Winston, Camel, MEVIUS, and LD brands. Japan Tobacco Inc. was incorporated in 1985 and is headquartered in Tokyo, Japan.

www.jt.com

53,593

Full Time Employees

December 31

Fiscal Year Ends

Tobacco

Industry

Recent News: 2914.T

View More

Performance Overview: 2914.T

Trailing total returns as of 5/8/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

2914.T
12.01%
Nikkei 225 (^N225)
7.37%

1-Year Return

2914.T
11.88%
Nikkei 225 (^N225)
3.27%

3-Year Return

2914.T
136.68%
Nikkei 225 (^N225)
36.85%

5-Year Return

2914.T
216.74%
Nikkei 225 (^N225)
83.13%

Compare To: 2914.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2914.T

View More

Valuation Measures

Annual
As of 5/7/2025
  • Market Cap

    7.99T

  • Enterprise Value

    8.52T

  • Trailing P/E

    44.60

  • Forward P/E

    16.84

  • PEG Ratio (5yr expected)

    0.55

  • Price/Sales (ttm)

    2.54

  • Price/Book (mrq)

    2.12

  • Enterprise Value/Revenue

    2.70

  • Enterprise Value/EBITDA

    14.87

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.69%

  • Return on Assets (ttm)

    2.41%

  • Return on Equity (ttm)

    4.70%

  • Revenue (ttm)

    3.15T

  • Net Income Avi to Common (ttm)

    179.24B

  • Diluted EPS (ttm)

    100.84

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.08T

  • Total Debt/Equity (mrq)

    44.87%

  • Levered Free Cash Flow (ttm)

    193.84B

Research Analysis: 2914.T

View More

Company Insights: 2914.T

Research Reports: 2914.T

View More

People Also Watch